Covid-19: Allocation of remdesivir made up to May 16, says S

Covid-19: Allocation of remdesivir made up to May 16, says Sadananda Gowda


To ensure smooth supply of remdesivir used in the treatment of COVID-19 across the country, the allocation of the antiviral drug to the states and union territories has been made up to May 16, Union Chemicals and Fertilisers Minister Sadananda Gowda said on Friday.
The production capacity of remdesivir has been increased to 1.03 crore vials per month, up from 38 lakh vials per month earlier, the minister had said on Tuesday.
"Considering the requirement of Remdesivir in every state and ensuring its adequate availability, allocation of #Remdesivir has been made upto 16th May 2021. This will ensure smooth supply of Remdesivir across country so that no patient face difficulty in this #pandemic time," Gowda said in a tweet.

Related Keywords

Sadananda Gowda , Navdeep Rinwa , Rajiv Wadhawan , Department Of Pharma , Union Chemicals , Ministry Of Health Family Welfare , Fertilisers Minister Sadananda Gowda , Pharma Joint Secretary Navdeep Rinwa , Family Welfare Director Rajiv Wadhawan , சதானந்த கவுடா , நாவ்தீப் ரின்வா , துறை ஆஃப் பார்மா , தொழிற்சங்கம் இரசாயனங்கள் , அமைச்சகம் ஆஃப் ஆரோக்கியம் குடும்பம் நலன்புரி , உரங்கள் அமைச்சர் சதானந்த கவுடா ,

© 2025 Vimarsana